Etamsylate is administered intravividly, intramuscularly, in ophthalmology - subconjunctival and retrobulbar. Etamsylate can be administered intravenously drip in a 5% dextrose solution or in 0.9% solution of sodium chloride.
The dosage regimen is set individually, depending on the indications.
Adults: with prophylactic purpose for surgical interventions the drug is administered intravenously or intramuscularly 1 hour prior to surgery at a dose of 0.25-0.5 g (2-4 ml of 12.5% solution), if necessary t during the operation - in a dose of 0.25-0.5 g (2-4 ml 12.5% solution), with the danger of postoperative bleeding - 0.5-0.75 g (4-6 ml 12.5% solution) during the day.
For children: if necessary intraoperatively. Etamsylate is administered intravenously at the rate of 8-10 mg / kg body weight.
To stop bleeding ethamylate injected intravenously or intramuscularly 0.25-0.5 g (2-4 ml of a 12.5% solution), after which every 4 to 6 hours to 0.25 g (2 ml 12.5% solution) for 5-10 days.
When treating metro, menorrhagia ethamylate used in a single dose of 0.25 g (2 ml of 12.5% solution) intravenously or intramuscularly every 6-8 hours for 5-10 days.
With diabetic microangiopathy ethamylate injected intramuscularly for 10-14 days in a single dose of 0.25-0.5 g (2-4 ml 12.5% solution) three times a day. In ophthalmology ethamylate injected subconjunctivalally or retrobulbarno in a dose of 0.125 g (1 ml of 12.5% solution).